SCHEMBL2197728

SCHEMBL2197728

Cc1ccc(C(=O)NCc2ccncc2)cc1C(=O)c1ccc(N)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPK1 P28482 1/20 0.48
JAK2 O60674 1/20 0.47
TYK2 P29597 1/20 0.47
MAPK7 Q13164 1/20 0.45
MAPK14 Q16539 4/20 0.45
CYP3A4 P08684 2/20 0.45
LMNA P02545 2/20 0.45
MMP13 P45452 2/20 0.45
MMP2 P08253 1/20 0.45
STAT3 P40763 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CA2 P00918 1/20 0.44
EPHX2 P34913 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
NAMPT P43490 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199852 0.88 CYP1A2 (0.54) GAASMN1; SMN2KMT2ACYP3A4LMNA
SCHEMBL2197758 0.83 KDM4E (0.67) MEN1KMT2ACYP3A4LMNAALDH1A1
SCHEMBL2196637 0.81 HPGD (0.51) GAASMN1; SMN2MEN1KMT2AJAK2
SCHEMBL2195108 0.80 HPGD (0.55) SMN1; SMN2MEN1KMT2AMAPK1MAPK14
SCHEMBL2199931 0.80 MAPK14 (0.59) GAASMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL14817967 0.79 GAA (0.63) GAASMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27655267 0.78 MAPK14 (0.48) GAASMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL2198191 0.76 SRD5A2 (0.47) GAASMN1; SMN2JAK2TYK2MAPK14
SCHEMBL13947076 0.75 NR1H4 (0.71) GAASMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL2199870 0.75 EPHX2 (0.40) SMN1; SMN2MEN1KMT2AMAPK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 GAA 2276/4885SMN1; SMN2 4625/4885MEN1 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.